Diacomit® (stiripentol) is now indicated for use with clobazam to treat seizures associated with Dravet syndrome in patients at least six months of age and weighing at least 7kg (15.4 pounds).

• First FDA approved in 2018, Diacomit was originally indicated only for use in patients at least two years of age.
• Recommended daily dosing is 50mg/kg of the patient’s weight, divided into two to three doses and taken by mouth with water during a For patients who weigh less than 10kg (22 pounds), dosing frequency should not exceed twice daily. For all patients, daily dosing should not exceed 3,000mg.